Multiplexed Diagnostics Market Analysis by Key Players, End Users and CAGR Forecast to 2022-2030

The global multiplexed diagnostics market for the historical period 2017–2018 and forecast period 2019–2027, rise in private and public funding for genomics and personalized medicine and growing demand for advanced diagnostic technology for accurate diagnosis of life-threatening diseases are projected to drive the global multiplexed diagnostics market during the forecast period

According to the report, the global multiplexed diagnostics market was valued at US$ 8.7 Bn in 2018 and is anticipated to grow at a CAGR of 17.9% from 2019 to 2030

Get the sample copy of report@ https://qyresearchmedical.com/sample/111644

Rise in private and public funding for genomics and personalized medicine: Key Driver

Significant private and public funding for genomics and personalized medicine is a key factor driving the global multiplexed diagnostics market.

For instance, the Europa Organization supports innovative companies in the development of new products. Blood Cancer Research Fund provided financial assistance to the University of California San Diego (UCSD) to study the effect of PCR duplicates in deep sequencing experiments and potential biasing. In September 2014, UCSD published results in the journal of Genome Biology.

Furthermore, growing demand for automated equipment & multifaceted analytical strategies and rising demand for advanced diagnostic technology for accurate diagnosis of life-threatening diseases

Moreover favorable regulatory scenario for new product launch and multiple usage of multiplexed diagnostics technology are some of the major factors responsible for the growth of global multiplexed diagnostics market.

View full report@ https://qyresearchmedical.com/report/multiplexed-diagnostics-market-technologies-very-high-density-high-density-medium-density-low-density-and-next-generation-sequencing-assays-applications-infectious-disease-diagnostics-oncology-autoimmune-019-2030/111644

High cost associated with multiplexed diagnostics assay hamper the market growth

Lack of skilled labor and high cost associated with multiplexed diagnostics assay can restrain the market growth.

Moreover Reimbursement structure for diagnostics test that uses multiplexed assays is unclear by private as well as public payers as compared to conventional diagnostic tests which can restrain the global multiplexed diagnostics market

Global multiplexed diagnostics Market: North America dominated the global market

On the basis of region, the multiplexed diagnostics market is segmented as North America, Europe, Asia-Pacific, Latin America, and Middle East & Africa.

North America region dominated the global market owing sequencing along with higher awareness, significant health care spending in overall national budgets, early availability of advanced technologies, and higher penetration of research activities across the country.

However, Asia-Pacific region is considered as the most lucrative market during the forecast period from 2019 to 2027. The growth is mainly ascribed to factors such as developing countries such as China and India offer lucrative growth prospects in the multiplexed diagnostics market due to factors such as improving health care infrastructure, rising private and public investment in life science research, and technological advancements.

Global Multiplexed diagnostics Market: Competitive Landscape

This report profiles major players in the global multiplexed diagnostics market based on various attributes such as company overview, financial overview, product portfolio, business strategies, and recent developments

The global multiplexed diagnostics market is highly consolidated, with a few global players accounting for a major share in market.

Purchase Complete Report Now@ https://qyresearchmedical.com/report/checkout/111644/2900

Leading players operating in the global multiplexed diagnostics market are

  • Agilent Technologies
  • bioMérieux SA
  • Bio-Rad Laboratories, Inc.
  • Illumina, Inc.
  • F. Hoffmann-La Roche Ltd.,
  • Hologic, Inc.
  • Luminex Corporation
  • Siemens Healthineers
  • Thermo Fisher Scientific, Inc.
  • Abbott Laboratories

Key Questions Answered in Global Multiplexed Diagnostics market Report

  • What is the scope of growth of companies in the global multiplexed diagnostics market?
  • What will be the Y-o-Y growth of the global multiplexed diagnostics market between 2019 and 2027?
  • What is the influence of regulatory scenario on the global Multiplexed Diagnostics market?
  • Will North America continue to be the most profitable market for multiplexed diagnostics providers?
  • Which factors are anticipated to hamper the growth of the global multiplexed diagnostics market during the forecast period?
  • Which are the leading companies in the global multiplexed diagnostics market?

Global Multiplexed Diagnostics market – Segmentation

Technology

  • Very High Density Multiplexed Assays
  • High Density Multiplexed Assays
  • Medium Density Multiplexed Assays
  • Low Density Multiplexed Assays
  • Next Generation Sequencing

Application

  • Infectious Disease Diagnosis
  • Oncology
  • Autoimmune Diseases
  • Cardiac Diseases
  • Allergies
  • Others

End-user

  • Academic Research Institutes
  • Hospitals
  • Diagnostic Laboratories
  • Pharmaceutical Companies
  • Clinical Research Organizations

Region

  • North America
  • Europe
  • Asia Pacific
  • Latin America
  • Middle East & Africa

TABLE OF CONTENT

1. Preface

1.1. Report Scope and Market Segmentation

1.2. Research Highlights

2. Assumptions and Research Methodology

2.1. Assumptions

2.2. Acronyms Used

2.3. Research Methodology

3. Executive Summary

3.1. Global Multiplexed Diagnostics Market Snapshot

4. Market Overview

4.1. Product Overview

4.2. Demographics & Market Indicators

4.3. Key Industry Events

4.4. Global Multiplexed Diagnostics Market Size (US$ Mn) Forecast, 2017–2027

4.5. Global Multiplexed Diagnostics Market Outlook

4.6. Porter’s Five Forces Analysis

5. Market Dynamics

5.1. Drivers and Restraints Snapshot Analysis

5.2. Drivers

5.3. Restraints

5.4. Opportunities

6. Global Multiplexed Diagnostics Market Analysis, by Technology

6.1. Introduction

6.2. Key Findings

6.3. Global Multiplexed Diagnostics Market Value Share Analysis, by Technology, 2017-2027

6.3.1. Very High Density Multiplexed Assays (> 10,000-plex)

6.3.2. High Density Multiplexed Assays (500 ≤ plex ≤ 10,000)

6.3.3. Medium Density Multiplexed Assays (plex < 500)

6.3.4. Low Density Multiplexed Assays (plex ≤ 5)

6.3.5. Next Generation Sequencing Assays

6.4. Global Multiplexed Diagnostics Market Attractiveness Analysis, by Technology, 2019–2027

6.5. Key Trends

7. Global Multiplexed Diagnostics Market Analysis, by Application

7.1. Introduction

7.2. Key Findings

7.3. Global Multiplexed Diagnostics Market Value Share Analysis, by Application, 2017 -2027

7.3.1. Infectious Disease Diagnostic

7.3.2. Oncology

7.3.3. Autoimmune Diseases

7.3.4. Cardiac Diseases

7.3.5. Allergies

7.3.6. Others (pregnancy & fertility testing, etc.)

7.4. Multiplexed Diagnostics Market Attractiveness Analysis, by Application, 2019-2027

7.5. Key Trends

8. Global Multiplexed Diagnostics Market Analysis, by End User

…….

Purchase Complete Report Now@ https://qyresearchmedical.com/report/checkout/111644/2900

You can place an order or ask any questions, please feel free to contact sales@qyresearchmedical.com | +1 9197 992 333

About Us

QYResearch Medical, focuses on custom research, management consulting, IPO consulting, industry chain research, and data base & seminar services. The company owns large basic databases (such as National Bureau of Statistics Database, Customs Import and Export Database, Industry Association Database, etc.), expert resources (including industry experts who own more than 10 years experiences on marketing or R&D in industries of healthcare services, medical technology & devices, etc.), professional survey team (the team members obtained more than 3 years market survey experience and more than 2 years deep expert interview experience), and excellent data analysis team (SPSS statistics and PPT graphics process team).

QYResearch Medical has more than 4000 global well-known customers, covering more than 30 industries including pharmaceuticals, medical technology & devices, healthcare services etc. Company services cover one-stop solution as Data-Analysis-Suggestion-Consulting Implementation. Research regions cover China, US, EU, Asia, Middle East and Africa, South America, Australia, and other regions in the world.

For Latest Update Follow Us:

https://www.linkedin.com/company/qyresearch-medical/

https://www.facebook.com/QYResearch-Medical-108186514228917/

https://twitter.com/qyresearchmedi